Our specialty is formulation in LNPs using the proprietary lipids and the unique microfluidic system we develop at RIBOPRO. Our LNPs display high mRNA delivery efficiency with low toxicity and immunogenicity, which is ideal for therapeutic use.
By using a novel core lipid system, our LNPs show a substantially lower bio-distribution to the liver, allowing the (active) targeting towards other organs. The ionizable lipids we developed have an extraordinary low toxicity and immunogenicity, while having a reasonably high endosomal escape activity.
Our services include:
- Producing nanoparticles of defined size (80-250nm, PDI <0.02)
- Buffer exchange (via dialysis)
- Dilution or concentration (0.01-2mg/ml mRNA, standard 0.1mg/ml)
- Quality control (size and PDI by DLS)
- Packaging and shipping